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Abstract 
 
Ordered protein assemblies are attracting interest as next generation biomaterials with a 
remarkable range of structural and functional properties, leading to potential applications in 
biocatalysis, materials templating, drug delivery and vaccine development.  This Review 
covers ordered protein assemblies including protein nanowires/nanofibrils, nanorings, 
nanotubes, designed 2D and 3D ordered protein lattices and protein-like cages including 
polyhedral virus-like cage structures. The main focus is on designed ordered protein 
assemblies, in which the spatial organization of the proteins is controlled by tailored non-
covalent interactions (including metal-ion binding interactions, electrostatic interactions and 
ligand-receptor interactions among others) or by careful design of modified (mutant) proteins 
or de novo constructs. The modification of natural protein assemblies including bacterial S-
layers and cage-like and rod-like viruses to impart novel function, e.g. enzymatic activity, is 
also considered. A diversity of structures have been created using distinct approaches, and 
this Review provides a summary of the state-of-the-art in the development of these systems, 
which have exceptional potential as advanced bionanomaterials for a diversity of 
applications.  
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1. Introduction 
 
Nature exploits protein assemblies of different types, ranging from viruses to microtubules 
and bacterial pili to large protein assemblies and bacterial S-layers. Extended protein 
assemblies are structural components of the extracellular matrix and biofilms for example, as 
well as cell motility structures.  Many viruses and bacterial microcompartments (BMCs) 
comprise ordered protein assemblies forming cages (discussed further in Section 5 below) 
around nucleic acids in the case of viruses or proteins in the case of BMCs, although others 
classes of viruses have extended assemblies (several are mentioned in Sections 2 and 3 
below). Proteins can also assemble around metal centres, for example in heme proteins or 
form large multi-component assemblies such as ribosomes. Advances in the understanding of 
computational protein design and genetic engineering methods have recently enabled the 
rational design of protein subunit structures to form regular 1D-, 2D- and 3D- superstructures 
including nanowires, nanotubes, 2D and 3D lattices and cage structures. This Review 
describes research in the field of engineered protein nanostructures, and summarizes the 
various methods that have been employed to fabricate such ordered protein assemblies. We 
do not consider natural protein assemblies, although modified variants are discussed. Also not 
included is a discussion of natural protein crystal structures, obviously a huge separate 
subject in its own right.  
 
Engineered protein assemblies are attractive for future applications due to their potential for 
large scale biosynthesis and their biofunctionality and biocompatibility. New emergent 
properties are expected from the nanostructured materials. Nanowire and nanotube structures 
may be created that have potentially valuable structural or (opto) electronic properties. 
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Assemblies based on enzymes may have enhanced catalytic behaviour. Synthetic vaccines 
can be designed inspired by, or based on, existing virus structures. Other applications for 
protein cages may exploit their potential to encapsulate cargo.   
 
In the most typical approach, fusion protein assemblies are created with pre-defined 
symmetry elements in order to define the directionality of the superstructure.1-12  Less 
commonly, proteins or peptides may be covalently linked (via flexible peptide or other 
spacers) in order to pre-impose directionality of assembly.13-14   
 
In a different approach, non-covalent interactions can be employed by modification of 
specific residues at the protein surface to enable - stacking15-18 or metal ion coordination,19-
22  for example. Again, the position and relative orientations of modification sites have to be 
chosen to design protein assemblies with specific symmetries which lead to defined 
superstructures. Alternatively, host-guest ligand-receptor interactions may be employed.15-17, 
23 In the simplest case, binary structures can be formed through electrostatic interactions.24-34 
 
The topic of ordered protein assemblies has been the focus of a number of previous 
reviews,35-41 and has been touched upon in broader reviews of protein-based materials.42 
Here, the state-of-the-art in this emerging field is summarized and exemplified by selected 
works which elegantly highlight the precision control of nanoscale protein assemblies that 
can be achieved using advanced design and synthesis methods. 
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2. Nanofibril and Nanoring Structures 
 
Linear arrays of proteins, i.e. nanofibrils or nanowires result from one-dimensional assembly 
through suitable binary head-tail interactions such as lock-and-key or ligand-receptor 
interactions or complementary binding interactions. As an example of assembly guided by 
ligand-receptor/lock-and-key interactions, linear structures have been constructed through 
cucurbit[8]uril, CB[8], host-guest interactions.23 Dimers of glutathione S-transferase (GST) 
were modified at the two N-termini with the tripeptide FGG which forms a host-guest 
complex with CB[8] with high binding constant. The resulting nanowires were characterized 
by diameters of 5 nm and were tens of nm in length.  
 
Using complementary binding peptide interactions, Usui et al. created so-called “nanolego” 
building blocks based on pairing of homotetrameric proteins modified at each of the four sub-
unit C-termini by a peptide (Fig.1a).1 Two protein fusion building blocks each containing 
four corner peptides were produced, the two types having complementary binding peptide 
units (Nanolego A and B, Fig.1a). Self-assembly of a mixture of the two leads to linear 
aggregation and nanofibril formation (Fig.1b). The tetrameric protein scaffold was a 
superoxide reductase (SOR) and the peptide units were either a mouse PDZ (signalling 
protein) domain or a PDZ-binding peptide (these two reversibly associate with high binding 
affinity). In a further development, the PDZ peptides were modified with cysteine mutations 
to enable step-wise extension of the aggregates based on disulfide bond formation. Finally, 
the fabrication of finite length aggregates (3-mers) was studied by introducing capping units 
with only two of the four binding units.1 
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Protein nanorings have been created using chemical inducers of protein dimerization, for 
example using a dimeric methotrexate MTX2-C9 which has high binding affinity for 
dihydrofolate reductase, DHFR (which was modified with extended linkers between the two 
subunits).43 Methotrexate is a therapeutic molecule used in chemotherapy and the treatment 
of automimmune diseases including arthritis, which acts by inhibiting DHFR. Fig.2a,b show 
the proposed assembly mechanism along with the DHFR2 variants prepared, while Fig.2c 
shows a representative TEM image of nanorings (20-28 nm in outer diameter). The closure 
into ring structures with defined sizes (i.e. number of subunits) is proposed to result from the 
balance between conformational flexibility and the entropy of oligomerisation.43  The same 
group has demonstrated ring structures with 8-30 nm diameter using fusion proteins DHFR-
Hint1 (dihydrofolate reductase-histidine triad nucleotide binding) with a variable length 
peptide spacer between the Hint1 unit and the DHFR protein.2 These fusion proteins were 
polymerized with a dimeric enzyme inhibitor molecule. The ratio of intra- to inter-molecular 
polymerization could be controlled via adjustment of fusion protein concentration, leading to 
oligomers containing 2-12 monomers. Inter-molecular cyclization was also favoured by 
reduction of the length of the linking peptide.2 
 
Small tetramer and trimer oligomers (‘nanorings’) can be made from complementary coiled-
coil forming peptides joined by a disordered flexible (GN)x peptide linker (Fig.3).
14 Parallel 
dimeric coiled-coil formation favors the formation of the trimeric and tetrameric structures, 
which were detected by analytical ultracentrifugation. The peptides with the shortest linker 
GN1 formed fibril structures (Fig.3), as imaged by TEM.
14 Peptide fibril structures are not 
considered further in this section, as this subject has been extensively reviewed elsewhere.44-
47 
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The rod-shaped M13 bacteriophage has been used as a nanowire template scaffold for a 
variety of applications. In one example, photocatalytic structures based on chemical grafting 
of photosensitizer and catalyst molecules to the M13 major coat protein p8 was reported.48 
The M13 bacteriophage comprises approximately 2700 copies of -helical coat proteins 
arranged around the viral DNA. Proteins with either chemically linked zinc porphyrin 
photosensitizer or an iridium oxide catalyst (attached non-covalently using an IrO2-binding 
peptide) were co-assembled, producing fibre (nanowire) structures. Light-driven water 
splitting was observed to be catalysed by the assemblies.48 The same strategy was used to 
produce cobalt oxide nanowires using p8 coat proteins modified with metal ion-binding tetra-
glutamate sequences.49 Additional incorporation of gold-binding  peptide produced hybrid 
gold-cobalt oxide wires as electrodes improved the charge storage capacity of model lithium 
ion batteries.49 In a further development, the M13 bacteriophage has been genetically 
engineered to incorporate a terminal peptide that binds single wall carbon nanotubes 
(SWCTs) and to incorporate peptides within the major coat protein that bind amorphous iron 
phosphate. These iron phosphate-based nanowire materials demonstrated excellent 
performance as cathodes for lithium ion batteries.50 An engineered M13 bacteriophage was 
also developed to produce a Co-Pt hybrid material with superparamagnetic properties.51 
Another recent example involves the use of M13 bacteriophages as scaffolds for metal 
deposition onto nanofoam meshes prepared by glutaraldehyde cross-linking of M13 modified 
with a glutamic-acid rich peptide at the N terminus.52 The free-standing metal nanofoams 
prepared may have use in the development of novel electrodes. 
 
Nanorings can be created by co-assembly of modified M13 bacteriophages and linker 
molecules.53 The M13 bacteriophage was genetically engineered to incorporate anti-
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streptavidin and hexahistidine peptides at opposite ends. Stoichiometric addition of 
streptavidin-NiNTA (Ni(II)-nitriloacetic acid hexahistidine-binding motifs) linkers led to the 
reversible formation of nanorings.53 Work on M13 bacteriophage and other viruses as 
scaffolds for nanomaterials development has been reviewed.54 
 
Electrostatic interactions between oppositely charged proteins can drive assembly into 
nanoring structures. In a recent example, supercharged Cerulean and GFP (Green Fluorescent 
Protein) variants were mixed to form toroid (nanoring) structures comprising two stacked 
octameric rings, as revealed by high resolution cryo-EM.30 
 
3. Nanotube Structures 
 
In this section, protein nanotubes created by design or modification of natural nanotube 
structures (rod-like viruses in particular) are considered. Peptide nanotube structures are not 
discussed in this section, this topic having been the subject of several recent reviews.55-60 
 
A subunit of cyotochrome c that comprises a four-helix-bundle haem protein has been used as 
a stable building block to produce nanotube and two- or three-dimensional crystalline 
structures via metal-coordination interactions.19 A variant of the protein modified to present 
two metal-binding bis-histidine motifs on its surface forms a C2-symmetric dimer structure 
stabilized by Zn2+ binding. Furthermore, one Zn2+ binding site is left open to binding by 
another dimer, the binding sites being positioned to favour orthogonal assembly, leading to 
helical chains. Appropriate solution conditions (high pH or low pH and high relative Zn2+ ion 
concentration) leads to fast formation of nanotubes, whereas the opposite conditions lead to 
slow nucleation into 2D and 3D crystals. Fig.4 shows a cryo-EM image with a model for the 
helical arrangement of the tetrameric (Zn2+-linked pair of dimers) building unit.19 The same 
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cytochrome c variant was later coupled via cysteine cross-linking to produce a dimer which 
was used to construct a tetrameric aggregating unit via Zn2+ coordination.19 The tetrameric 
dimer wraps helically to form the walls of nanotubes, of two types, which were observed 
according to the solution conditions (pH, buffer and Zn2+ excess). Slow nucleation conditions 
lead to the formation of 2D- and 3D- crystals in this system, as discussed in Section 4. 
 
The formation of nanotubes was observed by inducing the association of the homotetrameric 
protein soybean agglutinin (SBA) using a ligand containing both a galactose-based sugar unit 
to bind the protein and an aromatic motif (Rhodamine B, RhB) to drive - stacking 
interactions (Fig.5).15  A model for the helical wrapping of the proteins to form the nanotube 
wall could be obtained, based on electron tomographic imaging. The nanotube growth 
kinetics can be changed by temperature adjustment and the nanotubes could be dissociated by 
adding -cyclodextrin which binds the RhB.15 These structures resemble protein microtubule 
structures which are formed from dimers of the protein tubulin and have an outer diameter 24 
nm and lengths up to tens of micrometers. Microtubules are involved in mitosis and this, for 
example, is the basis of the activity of the anti-cancer drug taxol which hinders microtubule 
depolymerisation, promoting the arrest of mitosis and death of cancer cells.61-62 
 
Tobacco mosaic virus (TMV) has a rod-like structure, consisting of an array of coat proteins 
wrapped around an RNA core, leading to a nanotube capsid structure. This has been exploited 
to produce protein nanotubes by modifying the coat proteins, which has benefits because it is 
suggested that the display of antigens in a regular array leads to an enhanced immunogenicity 
compared to that induced by free proteins.63 Palmer and co-workers modified TMV coat 
proteins to enable biotinylation which then allows binding of streptavidin-tagged proteins, 
exemplified with GFP and an N-terminal fragment of the canine oral papillomavirus L2 
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protein. In both cases, nanotube structures which elicited higher immunogenic response than 
unconjugated (and un-assembled) protein were observed.63 In a similar fashion, an S123C 
mutant TMV coat protein has been used as a handle to attach electron donor and acceptor 
fluorescence chromophores, creating a scaffold for light harvesting.64-65 Unmodified TMV 
has a negatively charged surface and this has been used to template the deposition of 
cationically-modified gold nanoparticles via electrostatic interactions, leading to the 
formation of twisted fibre bundle structures.34 Magnetic alignment of these structures yielded 
a plasmonic polarizer. 
 
It is possible to design peptides that adsorb to particular species or surfaces. Using this 
inherent design flexibility, DeGrado’s group have developed antiparallel homo-hexameric 
coiled coil peptides that assemble into nanotubes around SWCTs.66 The peptides incorporate 
hydrophobic units, for example the C methyl of Ala, to facilitate binding to the hexagonal 
array of carbon atoms at the nanotube surface. 
 
4. 2D and 3D Crystal Structures 
 
Planar assembled protein structures exist in nature, for example S-layers are monolayers of 
(glyco)protein structure in the membrane of archaea and certain bacteria.67 S-layer protein 
structures have been reconstructed using tetrameric fusion proteins comprising one of a 
number of S-protein fragments and three streptavidin units.3 It was shown that these 
engineered constructs can form planar (oblique) lattice structures on flat surfaces or on cell 
wall polymer-containing cell wall fragments. The regular display of the streptavidin units 
enables binding of biotin and biotinylated protein such as ferritin in a regular pattern.3 It has 
been suggested that the periodic structure of S-layers is ideal for the development of affinity 
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matrices used in DNA, protein or antibody detection chips.68 S-layer proteins have also been 
considered as potential systems in vaccine development, due to the ability to present antigens 
at surfaces, along with adjuvant properties.68 S-layer structures additionally have potential in 
the development of immobilized biocatalysts, this having been demonstrated with fusion 
constructs incorporating extremophile enzymes.69-70 The fluorescent protein GFP has been 
incorporated into S-layer fusion proteins, enabling the creation of fluorescent biomarkers, pH 
indicators and the fluorescence imaging of the uptake of S-layered liposomes into cells.68 
Nanoparticle arrays can also be templated using the periodic structure of S layers, modified to 
display gold-binding cysteine residues,71 or utilising S-layer pores to grow cadmium sulfide 
quantum dots.72 Further details on these applications can be found in a review on S-layer 
structures.68 
 
Small cross-shaped aggregates (Fig.6) have been created using the C4-symmetric tetrameric 
catalytic protein RhuA, L-rhamnolose-phosphate aldolase.73 Each aldolase subunit was 
modified with a His6 tag for oriented binding to a planar surface as well as two tethered biotin 
uses to bind streptavidin with defined orientation. TEM revealed the presence of the expected 
cross-shaped network aggregates (Fig.6) on lipid monolayers when mixing biotinylated 
RhuA (bR) and bR modified with four streptavidins (bR.S4). The size of the small aggregates 
could be expanded by adding spacers of bis-biotinylated streptavidin (bbS, Fig.6). Rod spacers 
created by mixing bbS and S led to extended string-like structures.73 In a further development, 
the authors incorporated a Ca2+-binding -helix fragment of the enzyme serralysin between 
two PGAL (6-phospho--galactoside) proteins in a PGAL--PGAL construct and showed 
Ca2+-dependent switching, with a change in the separation of the two domains in the 
dumbbell-shaped fusion construct.73  
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The importance of designing the correct interface between proteins in multi-protein 
assemblies has been emphasized by several groups.24, 74-76 Grueninger et al. emphasized the 
importance of rigid side chain contacts and they designed mutants of proteins with such 
enhanced contacts.74 In particular, they modified monomeric PGAL to favour dimer 
formation by enriching contacts across local twofold axes and also produced tetramers from 
dimeric O-acetylserine sulfhydrylase (Oas) and urocanase (Uro) and modified tetrameric 
RhuA to favour pairwise association at the C4 axis surfaces. They also adapted the 
mycobacterial porin MypA to give a D8-symmetric unit forming tail-tail dimers. Fig.7 shows 
the modified protein structures along with the symmetry axes (and Fig.7d shows a TEM 
image showing linear association of the modified RhuA tetramer shown in Fig.7b).74  RhuA 
was used as a building block for 2-dimensional lattice assembly in a study where aggregation 
was controlled via several types of interaction via selective protein mutations.20 Specifically, 
single-disulfide, double-disulfide or double-histidine (metal coordinating) mutants were 
prepared. The self-assembly process is reversible via oxidation/reduction (of disulphide 
interactions between cysteines) or using EDTA, a zinc ion chelator in the case of the double-
histidine variant. Fig.8 shows the 2D lattices resulting from the assembly process which have 
different symmetries and a high degree of regularity. The C89RhuA variant was observed to 
form a number of defect-free 2D lattice polymorphs as a result of the dynamic single 
disulfide bond flexibility.  This material shows ideal auxetic behaviour, undergoing 
longitudinal expansion upon transverse stretching.20 Recent all-atom molecular dynamics 
simulations suggest that the free-energy landscape of these lattices is governed by solvent 
reorganization entropy.77 
 
Two-dimensional crystals as well as nanoribbon and nanowire structures were observed using 
the homotetrameric protein LecA from Pseudomonas aeruginosa.16 LecA is galactose-
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specific (which influences its infectivity) and mixing LecA assembly-inducing ligands 
containing galactopyranoside derivatives with pendant rhodamine B (RhB) units induces 
association of the proteins due to - stacking of the RhB units (cf. Fig.5 and associated 
discussion in the preceding section). Several stacking modes are possible depending on the 
ligand spacer length, which influences the geometry of - stacking interactions (Fig.9). This 
leads to assembly into the observed ribbon, 2D crystal or nanowire structures.16 Three-
dimensional crystal structures can be formed by using the sugar-lectin binding and - 
stacking interactions, using concanavalin A (con A), a homotetrameric protein with D2 
symmetry and mannose or lactose-based ligands incorporating aromatic Rhodamine B units 
to drive dimerization via - stacking (cf. for example Fig.5 and Fig.9).17 Platelet-shaped 
crystals were noted, and single crystal x-ray diffraction enabled determination of the distinct 
structures of the crystals formed with different ligand linkers.17 
 
The methods discussed so far rely on protein site modification, chemical coupling, or 
production of fusion proteins with defined geometries to drive self-assembly. In contrast, 
Sinclair et al. developed a class of fusion protein comprising units taken from protein 
assemblies with different rotational symmetries, linked at their termini along one symmetry 
axis.4 The fusion constructs are suitable for high-level, soluble expression in E. coli. These 
can aggregate into 1D or 2D structures termed crysalins. The components may be 
homologous (comprising only one type of subunit) or heterologous (combined two types of 
subunit). Using streptavidin/Streptag I as heterologous D2 assemblies and DsRed as a 
homologous D2 assembly, linear assemblies were observed (Fig.10a) whereas combination of 
E.coli ALAD (ALAD: aminolevulinic acid dehydrogenase) as D4 homologous assembly and 
streptavidin/Streptag1 as D2 heterologous unit led to 2D lattices (Fig.10b). The same D4 
homologous unit with Lac21E/Lac21K (heterotetrameric coiled coil peptides based on a Lac 
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repressor protein sequence, stabilized by Glu/Lys interactions78) as a C2 building block led to 
a different 2D lattice (Fig.10c).4 
 
An alternative approach is de novo design of proteins to create 2D lattices. Gonen et al. used 
the Rosetta protein modelling software to design proteins to form 2D lattices with defined 
symmetries.75 Specifically, from among the 17 distinct 2D lattice structures that can be 
formed from 3D objects, they selected a subset with two unique interfaces and building 
blocks with internal point symmetry. The designed proteins were then expressed in 
genetically engineered E. coli and the structures assembled in solution were observed by 
cryo-TEM.75 Fig. 11 shows the targeted 2D lattices along with representations of the protein 
packings and the designed interface structures along with TEM images and projection maps 
with overlaid design models. The construct for the P321 lattice is a trimer of -helices, that 
for the P4212 lattice is based on tetrameric -helices and that P6 is based on -helical 
hexamers.75 The same concept was used to design protein cage structures, as discussed 
further in Section 5. 
 
A novel route to porous 2D crystal structures was developed based on screening the protein 
data bank for small oligomeric proteins with defined rotational symmetry, with a central pore  
smaller than 5 nm, interfaces engineered to avoid steric clashes, flexible loops and termini 
oriented such that the C-terminus in one oligomer subunit can be linked via a short spacer to 
the N-terminus of a subunit in different oligomer (favouring inter-oligomer association).76 
This concept was exploited with a dimeric protein from S. typhimurium, STM4215 which 
forms a hexameric aggregate with a ~3 nm pore (Fig.12a). The protein was engineered such 
that the subunits were linked with a six-residue linker (Fig.12b), leading to the formation of 
the 2D honeycomb lattice shown in Fig.12c. Self-assembly was induced by addition of 
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calcium ions, since each subunit coordinates one Ca2+ ion. TEM observations confirmed the 
formation of the expected 2D honeycomb lattice (Fig.12d). Lanci et al. computationally 
designed a three-helix coiled coil peptide to form honeycomb (p6 symmetry) lattices, by 
designing a charged outer interface in a homo-trimeric coiled coil (Fig.13a) to favour 
pairwise complementary electrostatic interactions between helices in neighbouring peptides.24 
A single crystal structure for the designed protein confirmed the intended designed structure 
(Fig.13b).24 Honeycomb lattices are discussed further in Section 5, since such structures have 
been observed (in the case of building blocks with flexible linkers) to curve into cage 
structures.76 
 
In a pioneering paper, Dotan et al. showed that cubic structures based on diamond lattices can 
be prepared by creating dimers of the lectin concanavalin A, which has a tetrameric 
structure.79 The proteins were dimerized using bis-mannopyranoside, leading to a dumbbell 
shaped dimer which packs into a diamond lattice due to the imposed configuration of the 
protein subunits. As mentioned in Section 3, a modified cytochrome protein comprising 
dimers of C2-symmetric dimers via histidine-mediated Zn
2+-coordination that forms 
nanotubes can also assemble into 2D and 3D crystal structures under slow nucleation 
conditions.19 
 
The protein ferritin is interesting for protein nanomaterials design due to its highly symmetric 
cage-like structure. Ferritins comprise 24 subunits which assemble into a pseudo-spherical 
shell with octahedral symmetry. Each subunit consists of a four -helix bundle and a fifth 
short E-helix.25 The E-helices form the C4-symmetric channels (Fig.14), of which there are 
six in a ferritin shell (along with eight C3 axes). The channels in ferritin have sizes between 
0.3 nm and 0.4 nm and allow the transport of small ions and molecules. Yang et al. expanded 
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the C4-symmetric pore size (Fig.14) in mature soybean seed ferritin (mSSF) by E helix 
deletion from the H-1 half of the subunits (Fig.14).25 The expanded pore was able to 
accommodate poly(L-lysine) (degree of polymerization = 15), leading to tethering of the 
ferritin cages into a square array via electrostatic interactions (ferritin is rich in acidic 
residues).25 Zhou et al. have exploited the symmetry within the subunits of a ferritin protein 
in order to substitute aromatic residues located near the C4 symmetry axes (Fig.15a,b).
18 The 
substitution of phenylalanine (F) or tyrosine (Y) residues at a single site within each of the 24 
protein subunits was designed to induce directional aromatic stacking - interactions. These 
were shown to lead to the formation of planar 2D lattices of ferritin molecules in the case of 
F-substituted proteins (Fig.15c) or 3D cubic lattices in the case of Y-substituted proteins 
(Fig.15d) as shown schematically in Fig.15a.18 
 
Three-dimensional protein crystals can be developed as the basis of a new type of metal-
organic framework (MOF).21-22 The Tezcan group has developed MOFs based on ferritin 
arrays, initially substituting a Zn2+-binding histidine residue at residue 122 near to the C3 
axis.21 The ferritin proteins were then non-covalently linked using benzene-1,4-dicarboxylic 
acid, leading to bcc crystal structures.21 This work was extended to other divalent metal ions 
and alternative dihydroxamate linkers, leading to a range of MOFs with body-centred cubic 
or tetragonal lattices.22 
 
Native ferritin (human heavy chain) forms a fcc lattice (Fig.16a-c) mediated by Ca2+ K86Q 
interactions (Fig.16d). Tezcan and coworkers have shown that this lattice can be used as a 
template for polymerization of a polymer hydrogel network and that by appropriate choice of 
a responsive polymer, polymer gels containing embedded ferritin lattices that can be 
reversibly swollen by change of ionic strength or pH (Fig.16e).80 The polymer chosen was 
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poly(acrylate-co-acrylamide) which was prepared by free radical polymerization in the 
presence of APS (ammonium persulfate) and TEMED (tetramethylenediamine) as initiators 
and with N,N’-methylenebis(acrylamide) as cross-linker, and NaCl was included to limit 
swelling during polymerization. Post-polymerization swelling was initiated by placement in 
deionized water (Fig.16e), leading to an increase in lattice parameter from a = 19 nm to a = 
23 nm, determined by SAXS. The expansion was isotropic as confirmed by isotropic 
expansion of the faceted polyhedral gel crystals observed by optical microscopy. The gels 
exhibited self-healing behaviour, for example cracks in the polyhedral crystals induced by 
ion-induced contraction were observed to spontaneously seal due to the dynamic nature of the 
bonds between polymer chains and ferritin proteins.80 
 
Complexes of a zinc phthalocyanine with eight cationic groups with tetra-anionic pyrene 
derivative can bind to the anionic surface patches on ferritin (apoferritin), inducing 
crystallization into fcc packed co-crystals (Fig.17), with a lattice spacing a = 20 nm.81 The 
crystals retain the photoactivity of the phthalocyanine dye molecules including fluorescence 
and light-induced singlet oxygen production.  
 
Simply using electrostatic interactions between oppositely charged proteins, it is possible to 
produce co-crystals of avidin (which has net negative charge) and cowpea chlorotic mottle 
virus (CCMV) with a net positive charge, by mixing in aqueous solution.32 The crystals had a 
bcc structure with lattice spacing a = 35 nm. The use of avidin further enabled the pre- or 
post- assembly functionalization of the crystals with biotinylated molecules such as 
fluorescent dyes, enzymes or gold nanoparticles.32 In another example, binary crystals have 
been produced by co-crystallization of oppositely charged ferritin, surface modified with 
either basic (arginine or lysine) or acidic (glutamic acid or aspartic acid) residues.27 The 
binary crystal had tetragonal symmetry. Metal oxide nanoparticles could be sequestered 
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within either or both protein cages. This concept was developed to show that the 
crystallization could be modulated by metal ion (Mg2+) concentration, the binary tetragonal 
lattice at low Mg2+ concentration being replaced with a unitary cubic lattice at high [Mg2+].82 
In a related study, binary crystal structures were fabricated using mixtures of anionic proteins 
and cation-coated gold nanoparticles.31 The anionic proteins were cage-like ferritin 
(apoferritin or magnetoferritin) or CCMV, and these can encapsulate RNA or 
superparamagnetic iron oxide particles. 
 
Electrostatic interactions lead to the formation of a fcc lattice, as exemplified in mixtures of a 
P22 bacteriophage coat protein (virus-like particle, VLP) and a G6 (sixth generation) 
PAMAM dendrimer.28, 83 PAMAM dendrimers are cationic poly(amido amine) particles. The 
P22 bacteriophage coat protein (CP) was modified with a short anionic peptide (VAALEKE)2 
at the C terminus, producing an anionic particle. Mixing in appropriate proportions in suitable 
ionic strength conditions leads to the formation of a cubic lattice. Alternatively, amorphous 
aggregates could be prepared using a ditopic protein linker that binds the CP at multiple 
symmetry-specific sites. This linker can also be used to “cement” the ordered cubic structures 
formed in mixtures with PAMAM dendrimers, stabilizing the assembly against increase in 
ionic strength.28 Fusion proteins of the P22 CP with the enzymes ketoisovalerate 
decarboxylase (KivD) or alcohol dehydrogenase A (AdhA) formed capsid structures similar 
to those of the unmodified CP.83 The enzymatic activity was found to be retained in the G6 
dendrimer-modified CP assemblies, enzymes being confined within the VLPs. In a similar 
fashion, PAMAM dendrimers can be used to produce binary crystal structures (with hcp or 
fcc structure) with ferritin.33 The lattice constant is controlled by the size of the dendrimer 
(i.e. the generation number).  
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5. Cage Structures and Polyhedral Nanoparticles 
 
Many viruses and also some proteins such as ferritins84 or carboxysomes85 (involved in 
carbon fixation by bacteria) naturally form pseudo-spherical polyhedral cage structures. 
Clathrin-coated vesicles also have a cage structure, built from triskelion (three-arm) subunits 
of the Clathrin heavy chain (with bound light chains).86 Clathrin can form tetrahedral mini-
coat, hexagonal barrel or soccer ball structures in vitro.86 A discussion of these structures, and 
those of viruses, is outside the scope of the present review, although examples of virus-like 
protein nanoparticle assemblies and of virus-derived assemblies are considered. 
 
Controlling the association of coiled coil peptides by design has enabled the assembly of cage 
structures. Woolfson and coworkers designed a two-component system comprising a 
homotrimeric coiled coil linked to one of two heterodimeric coiled coils (containing 
complementary charged residues) through an external disulfide bond between cysteine 
residues (Fig.18a).87 The building blocks are expected to form a honeycomb lattice, however 
due to the inherent conformational flexibility, closed shell structures termed SAGES, self-
assembled cage-like particles, were observed with a diameter of approximately 100 nm.87 
Later, Ryadnov’s group developed cysteine-linked homodimeric coiled-coils with three 
different faces such that complementary electrostatic interactions between neighbouring 
dimers would favour formation of a honeycomb lattice (Fig.18b) or so-called tecto-dendrimer 
unit.26 Again, curling up into virus-like cages was observed in practice, with a diameter of 
approximately 12- 18 nm. The cage-like particles were able to transfect RNA and DNA. In 
related work, Castelletto et al. have prepared covalently-linked “triskelion” three-arm 
peptides containing the self-complementary -sheet sequence RRWTWE, based on a 
sequence from lactoferrin.13 These associate to give honeycomb lattices which curve into 
cage structures or capsules, able to encapsulate and deliver siRNA, and with additional 
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antimicrobial activity. This was ascribed to membrane pore formation, as imaged by AFM 
using model supported lipid bilayers.13 
 
Attaching coiled-coil peptides to the free C-terminus of a trimeric aldolase protein (KDPG 
aldolase from T. maritima) enables the design of cage-like assemblies by mixing homologues 
with complementary heterodimer-forming coiled coils.88 After expression of the C-terminal 
extended aldolase in E. coli, TEM and AUC (analytical ultracentrifugation) confirmed the 
presence of small assemblies in solution, with typical diameters 10-20 nm.88-89 A dimer was 
reported to be the most common assembled structure, although some tetrahedral and 
octahedral cages were detected.89 This work was extended by using an esterase C3-symmetric 
trimer linked via flexible spacers to C-terminally attached helical peptides, designed to form 
tetrameric coiled coils.5 The fusion protein was expected to form octahedral cage structures. 
The experiments confirmed the formation of such structures, provided the length of the 
spacer was sufficient, via mass spectrometry, AUC and TEM imaging.  
 
Yeates and coworkers have produced nanocage structures from fusion proteins, using the 
concept shown in Fig.19. The fusion protein comprised trimeric bromoperoxidase and the 
dimeric M1 matrix protein of influenza virus, connected by a nine-residue helical linker. The 
fusion protein was expected to have a tetrahedral shape, favouring the formation of 
dodecameric cage structures, which indeed were observed by TEM, after recombinant 
expression in E. coli and preparation of aqueous solutions.6 A crystal structure for the 
dodecameric cage structure was later obtained.90 The authors also reported a fusion protein 
that forms helical filaments based on the M1 protein fused to carboxylesterase linked by a 5-
residue -helical linker.6 In a similar fashion, fusion proteins designed to encode the 
information necessary to direct assembly have been used to produce 24-subunit cage 
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structures, based on positioning of trimeric building blocks along each of the three-fold 
symmetry aces of a tetrahedron.7 The protein structure and interaction modelling software 
Rosetta91 was then used to design the sequences at the interfaces of the building blocks, in 
order to enhance the stability of the interface through packing of suitable hydrophobic 
residues. In addition, structures were assembled from four trimeric and six dimeric building 
blocks aligned along the respective tetrahedral symmetry axes. After screening for solubility 
and compatibility with self-assembly, constructs were selected for experimental study. TEM 
images showed that the fusion proteins expressed in E. coli self-assembled into the designed 
structures in solution, and crystal structures were obtained for some of the assemblies.7  
 
Developing this concept, icosahedral protein cages have been created by design of 60-subunit 
fusion proteins using trimeric protein scaffolds arranged with icosahedral symmetry (i.e. 
arranging the trimer three-fold symmetry axis to be coincident with the 3-fold axes of the 
icosahedron).8 The distance from the icosahedron centre and the rotation angle of each trimer 
about its axis were then optimized for close packing, minimising steric clashes. The 
hydrophobic interfaces between the trimer building blocks were then filled by computer-
assisted design of amino acid sequences. Fig.20 shows cryo-TEM images along with 
reconstructions from the model design, confirming the icosahedral cage structure.8 In an 
extension of this work, this group also presented 120-subunit icosahedral protein cages with 
sizes 24-40 nm in diameter based again on designed fusion proteins, but using heteromeric 
components.9 Combinations of distinct building blocks among dimers, trimers and pentamers 
(according to the icosahedral symmetry elements) were used, for example 12 pentameric and 
20 trimeric building blocks aligned along the five-fold and three-fold icosahedral symmetry 
axes can produce an icosahedral protein cage, which can also be constructed from 
combinations of pentamers and dimers or trimers and dimers.9 In a parallel development of 
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the helical oligomer fusion strategy, a cubic cage- forming structure was designed and 
expressed in E. coli.10 The intension was to create a porous material, resembling a MOF, 
although long-range cubic ordering was not observed. The fusion protein comprises trimeric 
KDPG aldolase (the same used by Patterson et al.88) linked via a four-residue helical linker to 
the dimeric domain of protein FkpA (Fig.21a). The designed 24-subunit cage structure with 
octahedral symmetry is shown in Fig.21b. Single crystal x-ray diffraction and TEM 
confirmed the presence of the cubic cage structures after incubation of solutions of the fusion 
protein, although 12-mers, 18-mers and 24-mers were also detected by mass spectrometry 
analysis, TEM and SAXS.10  
 
Ferritin, which is widely used to prepare protein lattices as discussed in the preceeding 
section, is also a cage-like protein.92 Mutants have been engineered with Cys residues in 
metal-binding domains in order to sequester gold formed by reduction from Au3+ ions. A 
crystal structure of the cage with bound gold was obtained.92 Modification of ferritin 
nanocages by attachment of PEG facilitates penetration of the nanoparticles into tumor tissue 
and airway mucus.93-94 The PEG surface coating density was optimized by mixing highly 
PEGylated ferritin (attached via surface amines) with the native ferritin by disassembling the 
proteins and then reassembling by pH control. The anticancer drug doxorubicin was 
conjugated to PEGylated ferritin via an acid-labile linker as a therapeutic delivery vehicle.93 
 
The size of protein cages can be tuned by modification of the surface charge, as exemplified 
by recent work on the capsid-forming enzyme AaLS which in its native form adopts an 
icosahedral shape (60 sub units).95-96 Directed evolution led to a supercharged luminal capsid 
surface, able to better encapsulate oppositely (positively charged) cargo, in particular HIV 
protease, with an expansion in cage size corresponding to 180 or 240 sub units.95 The 
structure of the expanded supercharged cages was investigated in detail using cryo-TEM and 
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was found to comprise tetrahedrally- and icosahedrally- arranged pentameric units.96 By 
mixing negatively supercharged AaLS with cationically-supercharged ferritin, nested cage 
structures are obtained.29 This is good example in which tuning of electrostatic interactions 
on protein surfaces can be used to create new assemblies, in this so-called Matryoshka-type 
structures. 
 
Self-assembling peptide nanoparticles (SAPNs) have been designed based on peptides that 
contain two -helical domains linked by a two-glycine residue spacer, one of the 
oligomerization domains comprises a coiled coil that forms pentamers, while the other is 
from a trimeric coiled-coil domain (Fig.22a).97-98 The peptides are positioned to lie on the C5 
and C3 symmetry axes respectively of an icosahedron or dodecahedron. The nanoparticles 
contain 60 or 180 peptides were modelled based on an icosahedral structure (Fig.22b).98 The 
former nanoparticle structure is favoured for a de novo designed sequence containing cysteine 
residues (for which there is the potential for disulphide cross-linking)97 whereas the latter 
results from a modified construct with alanines replacing the cysteines and with extended 
terminal domains.98 The systems form roughly spherical nanoparticles with a diameter of 16 
nm (for the 60 subunit protein)97 or 27 nm (for the 180 subunit protein).98  In an extension of 
this research, variant SAPNs were prepared and characterized by SANS, STEM (which 
enables molar mass estimation) and DLS.99 Based on the determined particle size (the core 
radius from SANS was 35- 37 nm) and molar mass, it was proposed that these larger 
nanoparticles contain 240, 300 or 360 peptides, which were modelled as virus-like 
polyhedra.99 
 
Fusion of a de novo designed protein that forms a dimeric folded four-helix bundle with a 
trimeric domain from T4 bacteriophage fibritin leads to oligomers comprising multiples of 6-
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mers, as shown in Fig.23.11 Fitting of SAXS data enabled the envelope shape of the 
aggregates in solution to be obtained, which indicated the presence of tetrahedral and barrel-
shaped assemblies.11 
 
Virus-like particles (VLPs) have been modified to create nanoreactors, based on enzymes 
incorporated as fusion proteins with the scaffold proteins (SPs) which form the inner shell of 
viruses, which are surrounded with coat proteins (CPs). This is exemplified by the N-terminal 
conjugation of alcohol dehydrogenase (AdhD) to the SP of bacteriophage P22 (Fig.24).12 A 
P22 VLP is composed of approximately 420 copies of a 46.6 kDa coat protein (CP) that 
assembles into an icosahedral capsid with the aid of approximately 100–330 copies of a 33.6 
kDa scaffolding protein (SP). In the AdhD-SP conjugate, the C-terminal -helical scaffold 
protein facilitates co-assembly with the P22 CP, leading to particles indistinguishable from 
those of native P22. The AdhD gene is inserted into the pET11 expression vector (Fig.24). 
The catalytic activity was maintained, furthermore since P22 undergoes structural transitions 
on heating which lead to expansion or pore formation, the accessibility of the tethered 
enzymes can be adjusted thermally.12 In a parallel study, encapsulation of thermostable CelB 
glycosidase inside the P22 capsid was demonstrated using the same concept, again with no 
loss of enzyme activity and without impairing the ability of the P22 to undergo thermally-
induced morphology changes.100 The packaging of fluorescent proteins at the interior surface 
of P22 VLPs was demonstrated in a similar fashion.101 The concept was later extended to 
incorporate multiple (2 or 3) fused enzymes, including CelB and dimeric ADP-dependent 
glucokinase and also monomeric AT-dependent galactokinase in the 3-enzyme construct.102 
These enzymes can catalyse a cascade of coupled reactions, demonstrated with lactose as 
substrate. The activity of all encapsulated enzymes was confirmed, and the kinetic parameters 
were measured. 
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6. Conclusions and Future Perspectives 
 
In summary, a variety of approaches have been successfully demonstrated to assemble 
proteins into defined aggregates including cages and 1D, 2D or 3D structures. Protein 
assembly can be induced by non-covalent interactions such as metal-ion mediated pairing or 
hydrophobic side-chain interface engineering or electrostatic interactions using modified 
proteins or by de novo design of proteins. Protein mutants can be created exploiting C-or N-
terminal modifications or site-selective modifications, utilising suitable residues such as 
cysteines located suitably with respect to protein sub-unit symmetry axes. A range of natural 
multi- subunit proteins can be used for this purpose, there being a range of proteins with 
suitable C2, C3, C6, D2 and D4 subunit symmetries, among others, which can be used to 
produce 2D and 3D lattices, whilst an essential element of large cage structures is the 
inclusion of pentameric proteins in the design. It is possible to produce cage and 2D and 3D 
lattices with a remarkable degree of precision in the ordering using protein assemblies, 
provided appropriate design rules are followed.  
 
It will be interesting to follow further research developments that lead to the design and 
creation of novel lattice structures (and possibly aperiodic quasicrystals). Perhaps inspiration 
can be taken from the field of DNA origami, utilising stronger covalent interactions (such as 
multiple hydrogen bonds between nucleic acids) than have been exploited thus far. Other 
superstructures such as multi-ring (and interlinked) assemblies can be envisaged in analogy 
with the field of rotaxanes, with the related challenge to construct novel protein motors, 
inspired or distinct from natural ones. 
 
26 
 
Coiled coil proteins/peptides are an attractive design unit for simple de novo designed 
assemblies including polyhedral particles, ring structures, planar lattices and linear 
assemblies although coiled coils are combined with other elements to create cage and 3D 
lattice structures. On the other hand, assemblies based on natural proteins such as enzymes 
enables the potential exploitation of the native function, for example biocatalysis. Native and 
mutant proteins can be produced recombinantly (commonly using E. coli expression vectors), 
leading to the potential to scale up the synthesis. 
 
An alternative method to produce functional protein-based materials is to use protein 
assemblies as templates or scaffolds, as exemplified by the modification of polyhedral or rod-
like virus capsids with desired function by engineering of the coat or scaffold proteins. 
Another example is the use of bacterial S-layers to produce two-dimensional protein arrays, 
modified to enable metal templating or to create planar catalysts by positioning enzymes. 
Materials with remarkable catalytic and optoelectronic properties have been engineered in 
this way. These may have a role in addressing important challenges, for example in 
photocatalytic water oxidation or in CO2 fixation, as discussed above, and related 
applications in clean energy generation can be envisaged, by choice of appropriate enzymes. 
Since enzyme cascades have important roles in vivo, their engineering using protein 
assemblies is also an exciting avenue for future developments. 
 
As well as applications in biocatalysis, protein assemblies have potential in the creation of 
novel porous materials for separation and cage-like structures can be used to encapsulate and 
deliver cargo such as drug molecules, in a targeted manor (exploiting or modifying the 
protein coating to target particular cell functionalities). Alternatively, the intrinsic properties 
of such particles could be used to induce immunogenicity, with the potential additional 
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benefits arising from self-adjuvant properties. Another class of therapeutic approaches may 
involve the modification of the assembly pathway of protein superstructures such as 
microtubules, which is the basis of taxol’s anticancer activity. There are many related 
examples of protein structures (e.g. extracellular protein assemblies, ion pumps etc) involved 
in disease progression which have not yet been targeted. 
 
As yet, there are few examples of dynamic engineered protein assemblies, although in one 
recent example it has been demonstrated that a transition in 2D lattice structure of RhuA 
variant crystals (discussed in detail in Section 4) can be achieved by vigorous mixing and 
sedimentation (or by reversible Ca2+ - induced switching).77 There is considerable scope to 
produce new responsive materials by incorporating biological motor protein elements 
(myosins, dyneins, ATPase etc). This is an area with great potential to produce innovative 
active biomaterials. 
 
Considering the impressive examples outlined in this Review, it should be clear that protein 
materials are very promising components of next generation structural and functional 
biomaterials based on the unprecedented diversity of structures and properties that have 
evolved in natural proteins or can be designed into de novo constructs.   
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Figures 
 
 
 
Fig.1. (a) Concept to construct Nanolego A and Nanolego B building blocks from the 
homotetrameric S4 protein (superoxide reductase) modified with peptides Ba and Bb (PDZ 
domain peptide and PDZ-binding peptide) by creating fusion proteins using the subunit C- 
termini (shown). (b) Pairwise linear self-assembly leads to nanofibril formation. Reproduced 
from ref.1 with permission of John Wiley and Sons. 
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Fig.2. (a) Nanoring (toroid) formation using(bis-methotrexate MTX2-C9 binding to E. coli 
dihydrofolate reductase variants with extended spacers between the two subunits (b), (c) 
TEM image showing nanorings assembled in a solution of 1DD-G with MTX2-C9. 
Reproduced with permission from ref. 43  Copyright 2006 American Chemical Society. 
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Fig.3. Dimeric coiled coil peptides with a flexible (GN)x linker between the two 
complementary helical peptides can form extended fibrils (x=1), triangular trimers (x=3) or 
square tetramers (x=4). Reproduced with permission from ref. 14 Copyright 2012 American 
Chemical Society. 
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Fig.4. Nanotube structure from assembly of a designed cytochrome-based protein subunit.19 
(a) Cryo-TEM image of a representative nanotube, (b) Helical arrangement of tetrameric 
proteins into a nanotube structure stabilized by zinc ion coordination at the interfaces (i-
faces) shown, Zn1 for example denotes the dimer of C2-symmetric dimers forming the 
tetrameric building block. (c) Models for the outer (top) and inner (bottom) nanotube surfaces 
showing ridges and plateaus as shown side-on in (b). Reprinted by permission of Springer 
Nature from ref. 19 Copyright 2012. 
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Fig.5. Soybean agglutinin (SBA) is a homotetrameric protein with D2 symmetry. Addition of 
designed ligands incorporating a galactosamine (shown) or galactopyranoside unit able to 
bind SBA linked to a Rhodamine B unit able to undergo - stacking interactions which 
drives protein association, leading to helical wrapping into nanotubes (scale bar= 25 nm). 
Reproduced with permission from ref.15 Copyright 2016 American Chemical Society. 
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Fig.6. (a) Schematic to show modification of protein RhuA with eight biotins (bR), showing 
two of them binding to streptavidin (S), this in turn binding to biotinylated streptavidin 
linkers(bbS). The C terminal (Ct) units are highlighted, these are sites for hexahistidine 
tagging. (b,c) Representative TEM images of aggregates of bR and bR.S4 on lipid monolayers. 
The scale bars indicate 200 nm. From ref.73 Reprinted with permission from AAAS.  
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Fig.7. Modification of protein interfaces (mutations marked by purple spheres) to favour 
small oligomers.74 (a) Crystal structure of C2-symmetric UroA tetramer showing the two-fold 
molecular symmetry axis (red) and four local twofold axes relating the cores (black lines), (b) 
Octamer formed by dimerization of RhuA dimer with D4 symmetry, (c) RhuB octamer with 
C2 symmetry, (d) Negative stain TEM image of RhuE showing assembly of fibers, the inset 
scale bar shows a RhuA octamer to scale, (e) Native mycobacterial porin, with the deleted 
membrane-immersion part indicated by the box, giving MypA, (f) D8-symmetric assembly of 
two MypA molecules (top and bottom rings). The positions of the 52-residue deletions are 
marked by red spheres. From ref. 74 Reprinted with permission from AAAS. 
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Fig.8. Distinct 2D lattices formed by the indicated RhuA mutants. (i) Low magnification 
TEM images, (ii) High magnification TEM images, (iii) Fourier transforms of images in 
column (ii), (iv) Reconstructed 2D images from the Fourier transforms, (v) Structural models 
based on (iv). Reprinted by permission of Springer Nature from ref.20 Copyright 2016. 
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Fig.9. Galactose-based ligand-driven assembly of LecA homotetrameric proteins. (a) 
Structure of the LecA tetramer (protein data bank pdb id 4LKD), (b) Chemical structures of 
ligands RnG (n = 1 to 5) and R4M, (c) Illustration of dimerization, (d) Possible arrangements 
of LecA/RnG giving rise to different 1D and 2D nanostructures. Reproduced from ref. 16 with 
permission of John Wiley and Sons. 
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Fig.10.  Fusion of protein assembly elements leads to 1D and 2D superstructures (termed 
crysalins). Left column:  Schematic of assembly units showing symmetry elements, Second 
column: Protein/peptide components incorporated in fusion proteins, Third column: Designed 
structures, Right column: TEM images of observed structures. Reprinted by permission of 
Springer Nature from ref. 4 Copyright 2011. 
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Fig.11. Creation of designed 2D lattices by protein design. (A, F, K) targeted lattices with 
(inset) protein subunit arrangements, (B, G, L) models for designed proteins packed into the 
lattices shown above, (C, H, M) designed interface structure for the corresponding lattice 
structure in the same column, (D, I, N) cryo-TEM images of expressed protein lattices (white 
scale bars = 50 nm, black scale bars = 5 nm), with inset Fourier transforms (E, J, O).  
 Calculated projection maps (14 Å or 15 Å resolution) with overlaid protein designs shown 
on the right of each image. From ref. 75 Reprinted with permission from AAAS. 
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Fig.12. 2D lattices with p6 symmetry from a modified hexameric S. typhimurium STM4215 
protein TTM. (a) Ribbon structure showing native hexameric structure, (b) A dimer linked by 
an introduced short six-residue sequence (blue) with Rosetta designed modified interfaces 
(shown in black), (c) Top and side views of the expected 2D lattice with individual TTM 
dimers shown in different colours, (d) TEM image after incubating a protein sample with 
CaCl2 (inset: Fourier transform image showing hexagonal symmetry). Reproduced with 
permission from ref. 76 Copyright 2015 American Chemical Society. 
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Fig.13. Design of a honeycomb lattice from homotrimeric coiled coils. (a) Schematic of the 
p6 structure along with lattice symmetry elements, the parameters  and R adjusted in the 
peptide design are shown in the bottom scheme, (b) Two layers of the peptides showing H-
bonding at the interlayer interface facilitated by fixing the unit cell length c, (c) Electron 
density map from a single crystal structure (bottom) compared to a model structure (top). 
Reproduced from ref. 24 with permission of the authors. 
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Fig.14. (a) Schematic showing a ferritin C4-symmetry axis with pore, based on assembly of 
subunits shown on left with E-helix highlighted, (b) Surface charges on ferritin – orange 
spheres indicates negative charges and black spheres are positive charges, (c) Showing 
strategy to expand pore size by E-helix deletion from H-1 subunits in reconstructed mature 
soybean seed ferritin (rmSSF). The expanded pore size enables ingress of poly(L-lysine) 
which links proteins into a square array via electrostatic interactions. From Chemical 
communications by Royal Society of Chemistry (Great Britain). Reproduced with permission 
of Royal Society of Chemistry from ref. 25 
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Fig.15. 2D and 3D assemblies by aromatic substitution within the 24-subunit ferritin protein 
cage structure. (a) Schematic of ferritin structure showing C4 rotation axes and substitution 
sites near these axes, leading to 2D and 3D lattices depending on the aromatic residue 
substituted at Glu162. (b) Showing one of the 4-fold symmetry axes of human H-chain 
ferritin (pdb file 2FHA),103 (c) reconstructed image from FFT of a TEM image of a 2D 
oblique (rhombic) lattice for the phenylalanine substituted protein assembly, (d) SAXS 
pattern and one-dimensional intensity profile with indexed reflections corresponding to a 
simple cubic packed 3D structure (shown) for the tyrosine-substituted protein assembly. Parts 
(a), (c), (d) reproduced with permission from ref. 18 Copyright 2018 American Chemical 
Society. 
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Fig.16. Concept of swellable protein-embedded polymer hydrogel crystals. (a)-(c) Showing 
fcc packing in ferritin crystals (Protein Data bank Identifier, pdb id 6B8F), (d) Ca2+- mediated 
interactions leading to the packing of ferritin proteins in the crystal lattice, (e) Schematic of 
polymerization around the ferritin lattice scaffold to produce a reversibly swellable hybrid 
polymer-protein crystal hydrogel structure. Reprinted by permission of Springer Nature from 
ref. 80 Copyright 2018. 
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Fig.17. Complexes form between a zinc phthalocyanine derivative 1 and the tetra-anionic 
pyrene derivative PTSA (1,3,6-8-pyrene tetra-sulfonic acid) 2. These complexes bind to 
anionic patches on the apoferritin protein surface, leading to the formation of cubic crystals 
which retain the photo-activity of the phthalocyanine dye. Reproduced with permission from 
ref. 81 Copyright 2016 American Chemical Society. 
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Fig.18. (a) Schematic for coiled coil peptide assembly designed to self-assemble into a 
honeycomb lattice (which is observed to curve into a cage structure).87 Left: a homotrimeric 
coiled coil is linked via cysteine disulphide cross-linking to a homodimeric coiled coil. 
Mixing of either the top building block (centre, green and red) termed Hub A with coiled coil 
module B (basic coil peptide, blue) or Hub B (centre bottom 3-arm structure, green and blue) 
and module A (acidic coil peptide, red) leads to the formation of a honeycomb lattice (right). 
(b) Design of a dendrimer-like coiled coil peptide which forms a cage structure.26 A) 
Dendrimer architecture, B) cysteine-linked (yellow connector) coiled coil dimer, red and blue 
circles indicate glutamate and arginine residues respectively (c) Expected honeycomb lattice, 
(D) Model for RNA-filled capsule, empty shell and observed virus-like cage structure. Part 
(a) from ref. 87 Reprinted with permission from AAAS. Part (b) Reproduced with permission 
from ref. 26 Copyright 2016 American Chemical Society. 
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Fig.19. Fusion protein design. (a) Proteins with different sub-unit symmetries (here 2-fold 
and 3-fold rotation symmetry).6 (b) Fusion of two proteins (showing two possible 
geometries), (c) A ribbon diagram showing an example of a fusion construct where red and 
green proteins are linked by a short -helix (blue). The fusion requires one protein to have an 
initial -helix domain, the other protein must have a terminal -helix, (d) Schematic of a 2D 
honeycomb lattice that assembles from flat fusion dimers, (e) Schematic of a cage structure 
formed when the two proteins are twisted, as shown in part (b), right. Copyright 2001 
National Academy of Sciences. 
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Fig.20. Icosahedral protein cages. (a) Low-magnification cryo-TEM image showing cages in 
different projections, (b) Back-projections of structure along different symmetry axes based 
on the model, (c) class averages from cryo-TEM images (bottom), (d) Three-dimensional 
model of the icosahedral structure, and (e) projections corresponding to images in (b,c). 
Reprinted by permission of Springer Nature from ref. 8 Copyright 2016. 
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Fig.21. (a) Design of a fusion protein with appropriate oriented symmetry axes based on a 
trimeric protein (green) linked to a dimeric domain (orange) via a four-residue helical linker 
(blue), (b) Intended 24-subunit cubic cage structure with octahedral symmetry, the three-fold 
symmetry axes (cyan) and two-fold symmetry axes (magenta) of a cube being shown on the 
right. Reprinted by permission of Springer Nature from ref. 10 Copyright 2014. 
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Fig.22. Polyhedral peptide nanoparticles based on (a) building block comprising two linked 
coiled-coil peptides designed to form pentamers (green) or trimers (blue),97 with (b) models 
for their assembly into icosahedral particles, Top: Nanoparticle containing 60 peptides, 
Bottom: nanoparticle containing 180 peptides.98 Reprinted from refs. 97-98  with permission 
from Elsevier. 
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Fig.23. (a, b) Fusion protein from a designed four-helix dimer and a trimer from T4 phage 
fibritin, (c) Possible assemblies expected for the fusion protein, which are based on multiples 
of 6-mers. Reproduced with permission from ref. 11 Copyright 2015 American Chemical 
Society. 
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Fig.24. Incorporation of alcohol dehydrogenase into the pET expression vector for 
bacteriophage P22 produces the AlhD-SP conjugate (red, with C-terminal truncated scaffold 
protein shown in yellow) and the coat protein shown in blue leads to assembly of virus-like 
particles shown on the right, decorated with enzymes on the interior with model enzymatic 
activity shown (NAD: Nicotinamide adenine dinucleotide). Reproduced with permission 
from ref. 12 Copyright 2012 American Chemical Society. 
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